Literature DB >> 30129904

Radiofrequency Ablation Followed by Surgical Excision versus Lumpectomy for Early Stage Breast Cancer: A Randomized Phase II Clinical Trial.

Amparo García-Tejedor1, Anna Guma1, Teresa Soler1, Alazne Valdivieso1, Anna Petit1, Nayanar Contreras1, César G Chappuis1, Catalina Falo1, Sonia Pernas1, Ariel Amselem1, Maria J Plà1, Eulalia Fernández-Montolí1, Fernando Burdío1, Jordi Ponce1.   

Abstract

Purpose To compare the safety and efficacy of US-guided percutaneous radiofrequency ablation (RFA) as a local treatment for breast cancer with that of lumpectomy. Materials and Methods A prospective, randomized open-label phase II clinical trial (clinicaltrials.gov identification number NCT02281812) was conducted in a single institution from 2013 to 2017. Women with invasive ductal carcinoma of the breast measuring 2 cm or smaller were randomly assigned to receive RFA or lumpectomy alone (control group). Margin status at surgery, tumor cell viability after RFA (with nicotinamide adenine dinucleotide [NADH] and cytokeratin 18 [CK18] staining), cosmetic results, adverse events, and local recurrences were evaluated with univariable and multivariable analyses. Results Forty subjects (20 in the RFA group and 20 in the lumpectomy group) were evaluated. The mean participant age was 64 years (range, 46-86 years). NADH and CK18 staining demonstrated absence of tumor cell viability after RFA with at least one of the two techniques. The surgical margins were positive in 11 of the 20 participants in the lumpectomy group (55%) and four of the 20 in the RFA group (20%) (P = .02). Median follow-up was 25 months (range, 1-83 months). Local breast inflammation after surgery was higher in the RFA group than in the lumpectomy group (40% [eight of 20 participants] vs 5% [one of 20 participants], respectively; P = .01). Local infection occurred in three participants who underwent RFA (two of whom had undergone partial irradiation of the breast). None of the participants in the control group developed local infection. No participants had recurrence or the need for a second surgery during the study period. Conclusion This preliminary study showed that radiofrequency ablation was effective for local tumor control and that tumor-free margins were obtained more often with radiofrequency ablation than with lumpectomy. Surgical excision after radiofrequency ablation was infrequently associated with local infection. © RSNA, 2018 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2018        PMID: 30129904     DOI: 10.1148/radiol.2018180235

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

Review 1.  Heating technology for malignant tumors: a review.

Authors:  H Petra Kok; Erik N K Cressman; Wim Ceelen; Christopher L Brace; Robert Ivkov; Holger Grüll; Gail Ter Haar; Peter Wust; Johannes Crezee
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

Review 2.  Percutaneous Management of Breast Cancer: a Systematic Review.

Authors:  Yuqing Dai; Ping Liang; Jie Yu
Journal:  Curr Oncol Rep       Date:  2022-06-14       Impact factor: 5.075

3.  Efficacy and Safety of Radiofrequency Ablation for Breast Cancer Smaller Than 2 cm: A Systematic Review and Meta-Analysis.

Authors:  Lin-Yu Xia; Qing-Lin Hu; Wei-Yun Xu
Journal:  Front Oncol       Date:  2021-05-03       Impact factor: 6.244

4.  High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunity.

Authors:  Veronica M Ringel-Scaia; Natalie Beitel-White; Melvin F Lorenzo; Rebecca M Brock; Kathleen E Huie; Sheryl Coutermarsh-Ott; Kristin Eden; Dylan K McDaniel; Scott S Verbridge; John H Rossmeisl; Kenneth J Oestreich; Rafael V Davalos; Irving C Allen
Journal:  EBioMedicine       Date:  2019-05-23       Impact factor: 8.143

5.  Interventional oncology update.

Authors:  Alex Newbury; Chantal Ferguson; Daniel Alvarez Valero; Roberto Kutcher-Diaz; Lacey McIntosh; Ara Karamanian; Aaron Harman
Journal:  Eur J Radiol Open       Date:  2022-06-20

6.  Low-Level Radiofrequency Exposure Does Not Induce Changes in MSC Biology: An in vitro Study for the Prevention of NIR-Related Damage.

Authors:  Nicola Alessio; Elisa Santoro; Tiziana Squillaro; Domenico Aprile; Massimo Briccola; Paolo Giubbini; Raffaella Marchesani; Maria Rosaria Muoio; Monica Lamberti
Journal:  Stem Cells Cloning       Date:  2019-12-18

7.  Precision Breast-Conserving Surgery With Microwave Ablation Guidance: A Pilot Single-Center, Prospective Cohort Study.

Authors:  Hong Pan; Mengjia Qian; Hao Chen; Hui Wang; Muxin Yu; Kai Zhang; Siqi Wang; Jing Deng; Yi Xu; Lijun Ling; Qiang Ding; Hui Xie; Shui Wang; Wenbin Zhou
Journal:  Front Oncol       Date:  2021-05-26       Impact factor: 6.244

8.  TIGIT Blockade Exerts Synergistic Effects on Microwave Ablation Against Cancer.

Authors:  Yaping Chen; Hao Huang; Yuan Li; Wenlu Xiao; Yingting Liu; Rongzhang Chen; Yulan Zhu; Xiao Zheng; Changping Wu; Lujun Chen
Journal:  Front Immunol       Date:  2022-03-07       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.